ZFIN ChEBI: indolecarboxamide

Relationships

is a type of: indoles monocarboxylic acid amide

indoles monocarboxylic acid amide Show first 5 Terms
has subtype: (2-methyl-1-propyl-3-indolyl)-(1-naphthalenyl)methanone (4-benzylpiperidin-1-yl)-(5-amidinomethyl-3aH-indol-2-yl)methanone 1-(2-deoxy-5-O-phosphono-beta-D-ribosyl)-5-nitro-1H-indole-3-carboxamide 1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide 1-[(1R)-1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide ... Show All 76 Terms

(2-methyl-1-propyl-3-indolyl)-(1-naphthalenyl)methanone (4-benzylpiperidin-1-yl)-(5-amidinomethyl-3aH-indol-2-yl)methanone 1-(2-deoxy-5-O-phosphono-beta-D-ribosyl)-5-nitro-1H-indole-3-carboxamide 1-(2-Naphthylmethyl)-2,3-dioxo-indoline-5-carboxamide 1-[(1R)-1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide 1-[1-(1-ethylsulfonyl-4-piperidinyl)ethyl]-N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-3-indolecarboxamide 1-[1-naphthalenyl(oxo)methyl]-3-indolecarboxylic acid methyl ester 1-[2-(dimethylamino)ethyl]-5-methoxy-N-methyl-2-indolecarboxamide 1-Butyl-3-(1-naphthoyl)indole 1-methyl-N-(thiophen-2-ylmethylideneamino)-3-indolecarboxamide 1-Methylindole-3-carboxylic acid amide 1-{2-[(4-chlorophenyl)amino]-2-oxoethyl}-N-(1-isopropylpiperidin-4-yl)-1H-indole-2-carboxamide 1-{[5-(5-chloro-2-thienyl)isoxazol-3-yl]methyl}-3-cyano-N-(1-isopropylpiperidin-4-yl)-7-methyl-1H-indole-2-carboxamide 1-{[5-(5-chloro-2-thienyl)isoxazol-3-yl]methyl}-N-(1-isopropylpiperidin-4-yl)-1H-indole-2-carboxamide 1H-indole-5-carboxamide 3-[2-(dipropylamino)ethyl]-1H-indole-5-carboxamide 3-[[3-[(dimethylamino)methyl]anilino]-phenylmethylidene]-N,N-dimethyl-2-oxo-1H-indole-6-carboxamide 3-amino-4-methoxy-1H-indole-2-carbohydrazide 3-fluoro-Nalpha-(1H-indol-2-ylcarbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide 5-chloro-N-[(1S)-1-(4-fluorobenzyl)-2-(4-hydroxypiperidin-1-yl)-2-oxoethyl]-1H-indole-2-carboxamide 5-methoxy-N-(1-methoxypropan-2-yl)-1H-indole-2-carboxamide 6-[[[(5-bromo-3-phenyl-1H-indol-2-yl)-oxomethyl]hydrazinylidene]methyl]-2,3-dimethoxybenzoic acid [1,1'-biphenyl]-2-carboxylic acid, 4'-[[2,3-dimethyl-5-[[[(1s)-1-(4-nitrophenyl)ethyl]amino]carbonyl]-1h-indol-1-yl]methyl]- AM2201 AM2201 N-(4-fluoropentyl) isomer AM2232 AS-I-145 beta-d-glucopyranosiduronic acid, 4-[3-(1-naphthalenylcarbonyl)-1h-indol-1-yl]butyl beta-d-glucopyranosiduronic acid, 5-[3-(1-naphthalenylcarbonyl)-1h-indol-1-yl]pentyl CGS 7181 delavirdine devazepide Duocarmycin SA fosdevirine Ingliforib JWH 018 JWH 018 N-(5-chloropentyl) analog JWH 018 N-pentanoic acid metabolite JWH 073 N-(4-hydroxybutyl) metabolite JWH 073 N-butanoic acid metabolite JWH 398 JWH 412 N-(5-hydroxypentyl) metabolite JWH-018 N-(3-methylbutyl) isomer JWH022 JWH182 LSM-15495 LSM-36787 MAM2201 N-(4-hydroxypentyl) metabolite Methanone, (4-methoxy-1-naphthalenyl)[1-[2-(4-morpholinyl)ethyl]-1h-indol-3-yl]- Methanone, (4-methyl-1-naphthalenyl)[1-[2-(4-morpholinyl)ethyl]-1h-indol-3-yl]- Methanone, [1-(3-chloropentyl)-1h-indol-3-yl]-1-naphthalenyl- Methanone, [6-hydroxy-1-[2-(4-morpholinyl)ethyl]-1h-indol-3-yl]-1-naphthalenyl- Methoxybrassenin B N'-[(2-chlorophenyl)-oxomethyl]-5-(trifluoromethoxy)-1H-indole-2-carbohydrazide N'-[(3-nitro-6-oxo-1-cyclohexa-2,4-dienylidene)methyl]-1H-indole-3-carbohydrazide N-(1-isopropylpiperidin-4-yl)-1-(3-methoxybenzyl)-1H-indole-2-carboxamide N-(2,5-dichlorobenzyl)-5-ethyl-1H-indole-2-carboxamide N-(4-{1-[4-(4-acetylpiperazin-1-yl)-trans-cyclohexyl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide N-(4-{4-amino-1-[1-(tetrahydro-2H-pyran-4-yl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide N-(4-{4-amino-1-[4-(4-methylpiperazin-1-yl)-trans-cyclohexyl]-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxyphenyl)-1-methyl-1H-indole-2-carboxamide N-(thiophen-2-ylmethylideneamino)-1H-indole-7-carboxamide N-[(1-ethyl-3,5-dimethyl-4-pyrazolyl)methylideneamino]-1H-indole-3-carboxamide N-[(2S)-3-cyclohexyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]-1H-indole-2-carboxamide N-[2-(3,4-diethoxyphenyl)ethyl]-1H-indole-5-carboxamide N-[5-amino-4-(1,3-benzothiazol-2-yl)-3-oxo-2H-pyrrol-1-yl]-1H-indole-3-carboxamide N-[[1H-indol-2-yl(oxo)methyl]amino]carbamic acid (phenylmethyl) ester N-[[3-(2-benzofuranyl)-1-phenyl-4-pyrazolyl]methylideneamino]-1H-indole-3-carboxamide N-butyl-5-methoxy-1H-indole-2-carboxamide N-hydroxy-1-[(4-methoxyphenyl)methyl]-6-indolecarboxamide N-methyl-1H-indole-2-carboxamide PF-00835231 PF-07304814 Pruvanserin silodosin STS-135 talmapimod Show first 5 Terms

Phenotype

Phenotype resulting from indolecarboxamide

Phenotype where environments contain indolecarboxamide

Phenotype modified by environments containing indolecarboxamide

Human Disease / Model Data

Citations